3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Salivary Gland Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Anus Neoplasms
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Penile Neoplasms
1
Pelvic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Leukemia, Prolymphocytic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Interventions
fludarabine
5
Cyclophosphamide
5
aldesleukin
4
fludarabine phosphate
2
entinostat
2
aflibercept
2
Radiotherapy
2
Adoptive Transfer
2
rocakinogene sifuplasmid
1
pembrolizumab
1
oncogene protein E7, Human papillomavirus type 16
1
durvalumab
1
bintrafusp alfa protein, human
1
Vorinostat
1
VGX-3100
1
Ritonavir
1
Quality of Life
1
Psychiatric Rehabilitation
1
Platinum
1
Patient Reported Outcome Measures
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
MEDI0457
1
Isotretinoin
1
Interleukin-2
1
Interferon-alpha
1
Indinavir
1
Immunotherapy
1
Immunohistochemistry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Penile Neoplasms
×
Vorinostat
×
Gynecologic
×
Clear all
NCT04357873
2025-02-19
PEVOsq
UNICANCER
Phase 2
Completed
112 enrolled